No-Reflow Phenomenon in Patients with ST-Elevation Acute Myocardial Infarction, Treated with Primary Percutaneous Coronary Intervention: A Study of Predictive Factors

No abstract is available for this paper.

• Publication year

  2014

• Venue

  journal of cardio-thoracic medicine

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.22038/JCTM.2014.3491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of no-reflow phenomenon in culprit lesions involving a large side branch

  2014cited by this paper
• Cultivating prognosis following percutaneous coronary intervention: the American College of Cardiology/National Cardiovascular Data Registry risk score.

  2010cited by this paper
• Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.

  2010cited by this paper
• Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality.

  2007cited by this paper
• Recommendation to Develop Strategies to Increase the Number of ST-Segment–Elevation Myocardial Infarction Patients With Timely Access to Primary Percutaneous Coronary Intervention

  2006cited by this paper
• Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention.

  2005cited by this paper
• Microvascular Alterations After Temporary Coronary Artery Occlusion: The No-Reflow Phenomenon

  2004cited by this paper
• Primary angioplasty or thrombolysis for acute myocardial infarction

  2003cited by this paper
• No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.

  2003cited by this paper
• Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.

  2003cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin.

  2001cited by this paper
• Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia.

  2000cited by this paper
• Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia.

  2000cited by this paper
• Features and outcome of no-reflow after percutaneous coronary intervention.

  1995cited by this paper
• Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal coronary angioplasty.

  1995cited by this paper
• Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

  1994cited by this paper
• Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.

  1987cited by this paper
• The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration.

  1983cited by this paper

• Usefulness of platelet mass index in the prediction of angiographic no-reflow in patients with acute ST-segment elevation myocardial infarction

  2025cites this paper
• Impact of the Total Ischemia Time on No-Reflow Phenomenon Khalfallah et al

  2022cites this paper
• Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.

  2021cites this paper
• Very Early Versus Early Percutaneous Coronary Intervention in Patients with Decreased e-GFR after Successful Fibrinolytic Therapy

  2020cites this paper
• Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study

  2020cites this paper
• Coronary No-reflow Phenomenon: A Review of Therapeutic Pharmacological Agents

  2020cites this paper
• Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

  2017cites this paper
• No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction

  2016cites this paper
• Inappropriate Stent Placement Resulting in a Coronary Slow-Flow: Case Report

  2015cites this paper